Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PRURITUS THERAPEUTICS INDUSTRY
2.1 Summary about Pruritus Therapeutics Industry
2.2 Pruritus Therapeutics Market Trends
2.2.1 Pruritus Therapeutics Production & Consumption Trends
2.2.2 Pruritus Therapeutics Demand Structure Trends
2.3 Pruritus Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Antihistamines
4.2.2 Corticosteroids
4.2.3 Calcineurin Inhibitors
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 External Use
4.3.2 Oral
4.3.3 Injection
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Antihistamines
5.2.2 Corticosteroids
5.2.3 Calcineurin Inhibitors
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 External Use
5.3.2 Oral
5.3.3 Injection
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Antihistamines
6.2.2 Corticosteroids
6.2.3 Calcineurin Inhibitors
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 External Use
6.3.2 Oral
6.3.3 Injection
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Antihistamines
7.2.2 Corticosteroids
7.2.3 Calcineurin Inhibitors
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 External Use
7.3.2 Oral
7.3.3 Injection
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Antihistamines
8.2.2 Corticosteroids
8.2.3 Calcineurin Inhibitors
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 External Use
8.3.2 Oral
8.3.3 Injection
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Antihistamines
9.2.2 Corticosteroids
9.2.3 Calcineurin Inhibitors
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 External Use
9.3.2 Oral
9.3.3 Injection
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Abbott
10.1.2 J&J
10.1.3 Amgen
10.1.4 LEO Pharma
10.1.5 Novartis
10.1.6 Bayer
10.1.7 Pfizer
10.1.8 UCB Pharma
10.1.9 GlaxoSmithKline
10.1.10 Galderma
10.1.11 Huapont
10.2 Pruritus Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 Abbott
10.2.2 J&J
10.2.3 Amgen
10.2.4 LEO Pharma
10.2.5 Novartis
10.2.6 Bayer
10.2.7 Pfizer
10.2.8 UCB Pharma
10.2.9 GlaxoSmithKline
10.2.10 Galderma
10.2.11 Huapont
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Pruritus Therapeutics Product Type Overview
2.Table Pruritus Therapeutics Product Type Market Share List
3.Table Pruritus Therapeutics Product Type of Major Players
4.Table Brief Introduction of Abbott
5.Table Brief Introduction of J&J
6.Table Brief Introduction of Amgen
7.Table Brief Introduction of LEO Pharma
8.Table Brief Introduction of Novartis
9.Table Brief Introduction of Bayer
10.Table Brief Introduction of Pfizer
11.Table Brief Introduction of UCB Pharma
12.Table Brief Introduction of GlaxoSmithKline
13.Table Brief Introduction of Galderma
14.Table Brief Introduction of Huapont
15.Table Products & Services of Abbott
16.Table Products & Services of J&J
17.Table Products & Services of Amgen
18.Table Products & Services of LEO Pharma
19.Table Products & Services of Novartis
20.Table Products & Services of Bayer
21.Table Products & Services of Pfizer
22.Table Products & Services of UCB Pharma
23.Table Products & Services of GlaxoSmithKline
24.Table Products & Services of Galderma
25.Table Products & Services of Huapont
26.Table Market Distribution of Major Players
27.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
28.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
29.Table Global Pruritus Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
30.Table Global Pruritus Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
31.Table Global Pruritus Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
32.Table Global Pruritus Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f